Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hefei Yingtai Pharmaceutical is a specialized pharmaceutical company based in Hefei, China, focusing on the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company serves as a Contract Development and Manufacturing Organization (CDMO), offering comprehensive services from process R&D to commercial-scale production. Their product portfolio primarily supports therapeutic areas such as oncology, cardiovascular diseases, and anti-infectives, with a notable emphasis on anticoagulants. Hefei Yingtai is recognized for its expertise in complex chemical synthesis and maintains facilities that adhere to stringent GMP quality standards. By partnering with global pharmaceutical entities, the company plays a critical role in the supply chain for both generic and innovative drug products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei Yingtai Pharmaceutical.